Clinical Trials Browser

Phase NA × INDUSTRY × Other hematologic neoplasm × Clear all

NCT06572982 2026-01-14

Extension Study, Pilot, Compassionate Use of Azacitidine 300 mg Film Coated Tablets for Acute Myeloid Leukaemia (AML) Patients

Phase NA Active not recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT06685848 2026-01-07

Comparison of Hemanext ONE® System and Conventional Red Blood Cell Transfusion

Phase NA Recruiting

Other hematologic neoplasm

Hypoxia, Hematologic Neoplasms

NCT07167381 2025-12-23

xDRIVE for Florida-based Cancer Patients

Phase NA Recruiting

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Neoplasms, Recurrence

NCT06225050 2025-12-03

HAPLO2022

Phase NA Not yet recruiting

Other hematologic neoplasm

Hematologic Neoplasms

NCT06508775 2025-11-26

LONGSAFE

Phase NA Recruiting

DermatologicLymphoidOther hematologic neoplasm

Melanoma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05618041 2025-06-24

The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies

Phase NA Recruiting

LymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Multiple Myeloma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05956457 2025-04-20

PRO and Wearable Data Insights From Individuals With R/R Multiple Myeloma

Phase NA Recruiting

Other hematologic neoplasmPlasma cell

Multiple Myeloma, Hematologic Neoplasms

NCT05260203 2024-11-06

MargheRITA

Phase NA Completed

Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Treatment Adherence and Compliance, Amyloidosis, Anemia, Refractory, with Excess of Blasts, Hodgkin Disease, Multiple Myeloma, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Lymphoma, T-Cell, Neoplasms, Plasma Cell

NCT04938115 2024-06-14

Cell Therapy for CD7 Positive Acute Myeloid Leukemia or Mixed Lineage Leukemia

Phase NA Completed

LymphoidOther hematologic neoplasm

Leukemia, T-Cell

NCT05064787 2024-05-24

Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T Therapy

Phase NA Completed

LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Lymphoma, Follicular, Multiple Myeloma, Lymphoma, B-Cell, Hematologic Neoplasms, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05583734 2024-04-23

A Prospective Study of Conventional Bone Marrow Biopsy Versus Portomar(TM) Biopsy

Phase NA Recruiting

Other hematologic neoplasm

Hematologic Neoplasms

NCT05943314 2023-11-02

Clinical Study on Safety and Efficacy of Anti-CLL1 /+CD33 CAR T Cells in the Treatment of Acute Myeloid Leukemia

Phase NA Withdrawn

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT06035614 2023-09-13

Efficacy and Safety of 308-nm Excimer Lamp Combined With Tacrolimus vs Tacrolimus as Monotherapy in Treating Vitiligo on Children

Phase NA Completed

LymphoidOther hematologic neoplasm

Autoimmune Diseases, Skin Diseases, Vitiligo, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03229876 2023-07-24

Safety and Efficacy Evaluation of CD19-UCART

Phase NA Suspended

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05361356 2023-04-07

Spectral CT Clinical Trial

Phase NA Terminated

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05626400 2022-11-25

Clinical Study of Senl-T7 CAR T Cells in the Treatment of Relapsed and Refractory CD7+ Acute T-ALL/T-LBL

Phase NA Recruiting

LymphoidOther hematologic neoplasm

Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT05619861 2022-11-17

CAR-T Cells in the Treatment of Malignant Hematological Tumors

Phase NA Unknown

LymphoidOther hematologic neoplasmPlasma cell

Multiple Myeloma, Leukemia, B-Cell, Leukemia, T-Cell, Lymphoma, B-Cell

NCT05227898 2022-10-25

RESTORE

Phase NA Unknown

BreastGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidOther hematologic neoplasmThoracic

Breast Neoplasms, Colonic Neoplasms, Leukemia, Lung Neoplasms, Lymphoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Thyroid Neoplasms, Endometrial Neoplasms

NCT01903733 2022-07-19

Bosutinib Treatment Extension Study Only For Subjects With Chronic Myeloid Leukemia (CML) Who Have Previously Participated In Bosutinib Studies B1871006 Or B1871008

Phase NA Completed

281 enrolled 24 charts

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT04158726 2022-01-18

Integrating Geriatric Assessment for Older Patients Diagnosed With Acute Myelogenous Leukemia

Phase NA Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05017883 2021-11-04

TAA05 Cell Injection in the Treatment of Recurrent / Refractory Acute Myeloid Leukemia

Phase NA Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT02964325 2021-08-19

MIPLATE

Phase NA Terminated

422 enrolled 24 charts

Classical hematologyOther hematologic neoplasm

Thrombocytopenia, Hematologic Neoplasms

NCT04920500 2021-06-09

Bioequivalence of Daunorubicin Cytarabine Liposomes in Naive AML Patients

Phase NA Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04692948 2021-03-08

TAA6 Cell Injection In The Treatment of Patients With Relapsed / Refractory Acute Myeloid Leukemia

Phase NA Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04785833 2021-03-08

CD7 CAR-T in the Treatment of CD7 Positive Refractory Relapsed Acute Leukemia

Phase NA Unknown

LymphoidOther hematologic neoplasm

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT04336501 2020-12-17

Efficacy and Safety Evaluation of IM19 CAR-T Cell Therapy for MRD+ After Transplantation

Phase NA Unknown

Other hematologic neoplasm

Leukemia

NCT04610125 2020-10-30

Clinical Trial of CAR-T in the Treatment of Relapsed and Refractory Hematopoietic and Lymphoid Tissue Tumors in Children

Phase NA Unknown

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma

NCT04497701 2020-08-04

Evaluate the Efficacy and Safety of the Prophylactic Use of PEG-rhG-CSF in Children With Hematological Malignancies

Phase NA Unknown

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma

NCT02735291 2020-07-15

EECNTL

Phase NA Unknown

Other hematologic neoplasm

Leukemia

NCT03152526 2020-07-09

CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploidentical Donor Natural Killer (NK) Cell Based Therapy for AML Patients Not in CR

Phase NA Terminated

1 enrolled 5 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT02930850 2019-04-08

Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation

Phase NA Completed

Classical hematologyLymphoidOther hematologic neoplasm

Anemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03811457 2019-01-22

Immunotherapy With CD19 CAR T-cells in Patients With Relapsed or Refractory CD19+ Leukemia and Lymphoma

Phase NA Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma

NCT00088543 2015-03-18

Thymoglobulin to Prevent Acute Graft vs. Host Disease (GvHD) in Patients With Acute Lymphocytic Leukemia (ALL) or Acute Myelogenous Leukemia (AML) Receiving a Stem Cell Transplant

Phase NA Completed

LymphoidOther hematologic neoplasm

Graft vs Host Disease, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma